COMP <GO>
BBNX vs SIBN // ALTMAN Z-SCORE & DEBT/EQUITY
Beta Bionics Inc. (NASDAQ) VS. SI-BONE Inc. (NASDAQ) • 15-METRIC TALLY: BBNX 2
— SIBN 8
▲ ALTMAN Z-SCORE & DEBT/EQUITY LEADER: BBNX
LAST: $17.58 (-1.51%) • MKT CAP: $955.8M
balance-sheet
12.82
LAST: $22.41 (+2.66%) • MKT CAP: $1.00B
balance-sheet
8.73
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (BBNX VS. SIBN)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | BBNX | SIBN | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 55.40% | 79.60% | -24.20 | SIBN | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | -22.10% | -10.30% | -11.80 | SIBN | /roic <GO> |
| EV/EBITDA & P/E Valuation | — | — | — | TIE | /valuation <GO> |
| Free Cash Flow Yield | -5.88% | -0.90% | -4.98 | SIBN | /fcf-yield <GO> |
| Operating Margin | -60.00% | -11.10% | -48.90 | SIBN | /operating-margins <GO> |
| Net Profit Margin | -60.00% | -9.40% | -50.60 | SIBN | /net-margins <GO> |
| Revenue Growth (YoY) | 53.90% | 20.20% | +33.70 | BBNX | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 0.00% | 0.00 | TIE | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity ACTIVE | 12.82 | 8.73 | +4.09 | BBNX | /balance-sheet <GO> |
| Piotroski F-Score Quality | 4/9 | 6/9 | -2.00 | SIBN | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 41.5 | 58.6 | -17.14 | SIBN | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | — | — | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | — | — | — | TIE | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $955.8M | $1.00B | -$48.6M | SIBN | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | BBNX REV | SIBN REV | BBNX GROSS % | SIBN GROSS % | BBNX FCF | SIBN FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $100.3M | $200.9M | 55.4% | 79.6% | -$56.2M | -$9.1M |
| FY 2024 | $65.1M | $167.2M | 55.1% | 79.0% | -$51.7M | -$22.9M |
| FY 2023 | $12.0M | $138.9M | — | — | -$32.4M | -$18.7M |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
BBNX // BETA —
SIBN // BETA —